01/13/2025
7:00 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:05 AM | Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:05 AM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:30 PM | Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:00 PM | Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
| Form SC 13D/A | |
12/03/2024
4:48 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:50 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/19/2024
3:48 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/18/2024
7:02 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:27 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:00 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
5:00 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:51 AM | Akari Therapeutics (Subject)
| Form 425 | |
10/14/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
10/11/2024
3:52 PM | Akari Therapeutics (Filer)
| Form 424B3 | |
10/09/2024
3:27 PM | Akari Therapeutics (Filer)
| Form S-4/A | |
10/04/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
5:34 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:43 AM | Akari Therapeutics (Filer)
| Form S-4/A | |
09/18/2024
3:34 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:36 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
3:40 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
09/13/2024
4:30 PM | Akari Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2024
4:23 PM | Akari Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/06/2024
4:07 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Grab This Altcoin Before Trump's Crypto Announcement (Ad) Grab This Altcoin Before Trump's Crypto Announcement
Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
 Click here to check it out now |
08/23/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K/A | |
08/19/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:15 PM | Akari Therapeutics (Filer)
| Form NT 10-Q | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
WILLIAMS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
6:30 AM | Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
| Form SC 13D/A | |
06/07/2024
5:00 PM | Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
| Form SC 13D | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Akari Therapeutics (Subject)
| Form 425 | |
06/04/2024
7:02 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
7:05 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:47 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
4:27 PM | Akari Therapeutics (Subject)
| Form 425 | |
05/01/2024
4:04 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
8:45 PM | Akari Therapeutics (Issuer)
Jacques Rachelle Suzanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
4:25 PM | Akari Therapeutics (Subject)
| Form 425 | |
03/11/2024
4:24 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:28 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:34 AM | Akari Therapeutics (Subject)
| Form 425 | |
